Bharat Biotech’s COVAXIN® Phase III data published in The Lancet, Health News, ET HealthWorld
Hyderabad, November 12, 2021: Bharat Biotech, a global leader in vaccine development and innovation, announced today that the safety and efficacy analysis data from Phase III clinical trials of COVAXIN®…
